Nomogram for predicting pathological response to neoadjuvant treatment in patients with locally advanced gastric cancer: Data from a phase III clinical trial.
Han ShaoNai LiYi-Hong LingJi-Jin WangYi FangMing JingZhou-Wei ZhouYu-Jing ZhangPublished in: Cancer medicine (2024)
A good pathological response after neoadjuvant treatment was associated with an improved prognosis in LAGC patients. The nomogram we established exhibits a high predictive capability for GR, offering potential value in devising personalized and precise treatment strategies for LAGC patients.
Keyphrases
- locally advanced
- clinical trial
- end stage renal disease
- rectal cancer
- phase iii
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- open label
- lymph node
- randomized controlled trial
- radiation therapy
- neoadjuvant chemotherapy
- machine learning
- electronic health record
- combination therapy
- climate change
- phase ii study
- replacement therapy